These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 16956462)
1. Cutaneous reactions to transdermal therapeutic systems. Musel AL; Warshaw EM Dermatitis; 2006 Sep; 17(3):109-22. PubMed ID: 16956462 [TBL] [Abstract][Full Text] [Related]
2. Skin hypersensitivity reactions to transdermal therapeutic systems--still an important clinical problem. Jenerowicz D; Polańska A; Olek-Hrab K; Silny W Ginekol Pol; 2012 Jan; 83(1):46-50. PubMed ID: 22384639 [TBL] [Abstract][Full Text] [Related]
3. A review of contact dermatitis associated with transdermal therapeutic systems. Holdiness MR Contact Dermatitis; 1989 Jan; 20(1):3-9. PubMed ID: 2492460 [TBL] [Abstract][Full Text] [Related]
4. [Management of transdermal therapeutics in perioperative care]. Gentile A; Tran-Van D; Dardare E; Fritsch N; Benois A; Fontaine B Ann Fr Anesth Reanim; 2009 Apr; 28(4):311-20. PubMed ID: 19304449 [TBL] [Abstract][Full Text] [Related]
5. Allergic contact dermatitis from transdermal clonidine in a patient with mycosis fungoides. Polster AM; Warner MR; Camisa C Cutis; 1999 Mar; 63(3):154-5. PubMed ID: 10190065 [TBL] [Abstract][Full Text] [Related]
6. Transdermal drug delivery systems and skin sensitivity reactions. Incidence and management. Murphy M; Carmichael AJ Am J Clin Dermatol; 2000; 1(6):361-8. PubMed ID: 11702612 [TBL] [Abstract][Full Text] [Related]
7. Adverse dermatologic reactions to transdermal drug delivery systems. Hogan DJ; Maibach HI J Am Acad Dermatol; 1990 May; 22(5 Pt 1):811-4. PubMed ID: 2112162 [TBL] [Abstract][Full Text] [Related]
8. Allergic contact dermatitis from transdermal estradiol and systemic contact dermatitis from oral estradiol. A case report. Corazza M; Mantovani L; Montanari A; Virgili A J Reprod Med; 2002 Jun; 47(6):507-9. PubMed ID: 12092023 [TBL] [Abstract][Full Text] [Related]
9. Allergic contact dermatitis from nitroglycerin contained in 2 transdermal systems. Machet L; Martin L; Toledano C; Jan V; Lorette G; Vaillant L Dermatology; 1999; 198(1):106-7. PubMed ID: 10026420 [No Abstract] [Full Text] [Related]
10. Allergic contact dermatitis from nitroglycerin and estradiol transdermal therapeutic systems. Torres V; Lopes JC; Leite L Contact Dermatitis; 1992 Jan; 26(1):53-4. PubMed ID: 1534736 [No Abstract] [Full Text] [Related]
11. Allergic contact dermatitis from methacrylates in a nicotine transdermal patch. Dwyer CM; Forsyth A Contact Dermatitis; 1994 May; 30(5):309-10. PubMed ID: 8088155 [No Abstract] [Full Text] [Related]
12. Allergic contact dermatitis to oestradiol patches might have been expected. Batta K; Foulds IS BMJ; 1998 Jan; 316(7125):149. PubMed ID: 9462338 [No Abstract] [Full Text] [Related]
13. Allergic contact dermatitis caused by transdermal hyoscine. Gordon CR; Shupak A; Doweck I; Spitzer O BMJ; 1989 May; 298(6682):1220-1. PubMed ID: 2526675 [No Abstract] [Full Text] [Related]
14. Development and validation of an objective method of determining skin erythema to transdermal oestradiol patches. Ross D; Whitehead M; Pike B Br J Obstet Gynaecol; 1999 Mar; 106(3):279-83. PubMed ID: 10426650 [No Abstract] [Full Text] [Related]
15. Contact allergy to nicotine from a nicotine patch. Färm G Contact Dermatitis; 1993 Oct; 29(4):214-5. PubMed ID: 8281791 [No Abstract] [Full Text] [Related]
16. The promise of transdermal drug delivery. Nimmo WS Br J Anaesth; 1990 Jan; 64(1):7-10. PubMed ID: 2105738 [No Abstract] [Full Text] [Related]
17. Skin sensitivity and transdermal drug delivery. A review of the problem. Carmichael AJ Drug Saf; 1994 Feb; 10(2):151-9. PubMed ID: 8011180 [TBL] [Abstract][Full Text] [Related]